Details of the Drug

General Information of Drug (ID: DMJ2763)

Drug Name

IONIS-FB-LRx

Indication

Disease Entry	ICD 11	Status	REF
IgA nephropathy	MF8Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Antisense oligonucleotide

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04014335) A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Ionis Pharmaceuticals.